ST elevation myocardial infarction adjunctive percutaneous coronary intervention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 14: Line 14:
   MeshID        = |
   MeshID        = |
}}
}}
'''For patient information click [[Heart attack (patient information)|here]]'''
{{SI}}
{{SI}}
{{WikiDoc Cardiology Network Infobox}}
{{WikiDoc Cardiology Network Infobox}}

Revision as of 13:47, 1 July 2010

Myocardial infarction
ICD-10 I21-I22
ICD-9 410
DiseasesDB 8664
MedlinePlus 000195
eMedicine med/1567  emerg/327 ped/2520

For patient information click here

WikiDoc Resources for ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Articles

Most recent articles on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Most cited articles on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Review articles on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Articles on ST elevation myocardial infarction adjunctive percutaneous coronary intervention in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Images of ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Photos of ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Podcasts & MP3s on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Videos on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Evidence Based Medicine

Cochrane Collaboration on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Bandolier on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

TRIP on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Clinical Trials

Ongoing Trials on ST elevation myocardial infarction adjunctive percutaneous coronary intervention at Clinical Trials.gov

Trial results on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Clinical Trials on ST elevation myocardial infarction adjunctive percutaneous coronary intervention at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

NICE Guidance on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

NHS PRODIGY Guidance

FDA on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

CDC on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Books

Books on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

News

ST elevation myocardial infarction adjunctive percutaneous coronary intervention in the news

Be alerted to news on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

News trends on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Commentary

Blogs on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Definitions

Definitions of ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Patient Resources / Community

Patient resources on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Discussion groups on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Patient Handouts on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Directions to Hospitals Treating ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Risk calculators and risk factors for ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Healthcare Provider Resources

Symptoms of ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Causes & Risk Factors for ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Diagnostic studies for ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Treatment of ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Continuing Medical Education (CME)

CME Programs on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

International

ST elevation myocardial infarction adjunctive percutaneous coronary intervention en Espanol

ST elevation myocardial infarction adjunctive percutaneous coronary intervention en Francais

Business

ST elevation myocardial infarction adjunctive percutaneous coronary intervention in the Marketplace

Patents on ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Experimental / Informatics

List of terms related to ST elevation myocardial infarction adjunctive percutaneous coronary intervention

Cardiology Network

Discuss ST elevation myocardial infarction adjunctive percutaneous coronary intervention further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Vijayalakshmi Kunadian MBBS MD MRCP [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Adjunctive PCI

Stated simply, this is performance of a PCI in an open artery following fibrinolytic therapy. Adjunctive PCI is defined as the intent to administer fibrinolytic agent in the setting of STEMI, and the performance of PCI for partial success of the fibrinolytic agent is unintended. If there are clinical signs and symptoms of incomplete reperfusion, then adjunctive PCI is performed to further open a patent artery (one with TIMI grade 2 or 3 flow). The strategy differs from facilitated PCI, a strategy in which the intent is to administer a fibrinolytic agent, and the performance of PCI is intended to improve the fibrinolytic results.

Strategies that Adjunctive PCI should be distinguished from:

Primary PCI

Primary PCI is defined as the performance of percutaneous coronary intervention (PCI) (either conventional balloon angioplasty or coronary stent placement) in the setting of ST elevation MI (STEMI) without antecedent treatment with a fibrinolytic agent. The chapter on Primary PCI can be found here.

Facilitated PCI

Facilitated PCI is defined as the intent to perform a PCI (either conventional balloon angioplasty or coronary stent placement) in the setting of STEMI following treatment with either a full dose or half dose of a fibrinolytic agent. This approach is also termed a pharmaco-invasive strategy. This strategy differs from rescue or adjunctive PCI in that the intent of facilitated PCI is to perform PCI, and the administration of a fibrinolytic agent is intended to improve the PCI results. The chapter on Facilitated PCI can be found here.

Rescue PCI

Stated simply, this is performance of a PCI in a closed artery following fibrinolytic therapy. Rescue PCI is defined as the intent to administer a fibrinolytic agent in the setting of STEMI, and the performance of PCI for failure of the fibrinolytic agents is unintended. If there are clinical signs and symptoms of failure of the fibrinolytic agent to achieve reperfusion, then rescue PCI is performed to open the totally occluded artery. The strategy differs from facilitated PCI, a strategy in which the intent is to administer a fibrinolytic agent, and routinely perform PCI in the majority of patients even in the presence of or irrespective of signs and symptoms of successful fibrinolytic reperfusion. The chapter on Rescue PCI can be found here.

Adjunctive PCI

Data to support performance of adjunctive PCI on an open artery following fibrinolytic administration is sparse. Non randomized data from the TIMI studies published by Gibson et al did suggest a benefit of both rescue and adjunctive PCI following fibrinolytic administration [1].

Randomized, prospective clinical trials in the era of modern PCI techniques are sparse. In 1994, Ellis et al from the PAMI group [2] evaluated the benefits of PCI in patients in an open (patent) artery (Thrombolysis in Myocardial Infarction (TIMI) 2-3 flow grade) in the setting of STEMI following fibrinolytic therapy (n=108 patients). At the time the study was undertaken, TIMI 3 flow was felt to be associated with improved outcomes over TIMI grade 2 flow. It was therefore reasoned that improving flow from slow or TIMI grade 2 to normal, or TIMI grade 3 would be associated with better outcomes. The improvement in left ventricular ejection fraction (LVEF) from 90 minutes to hospital discharge was minimall better for patients who underwnet PTCA (51 +/- 12 to 52 +/- 11% for PTCA versus a decline from 55 +/- 10 to 53 +/- 12% for medical therapy, P = 0.06). In contrast, among patients with pre PTCA TIMI 3 flow, patients treated with medical therapy had a greater improvement in LVEF (54 +/- 10 to 54 +/- 8% for PTCA, versus 55 +/- 10 to 58 +/- 8% for medical therapy, P = 0.01). Among patients with pre PTCA TIMI 2 flow grade there were no differences in in-hospital death (6.1% PTCA versus 1.7% for medical therapy, P = 0.25) or congestive heart failure (18.4% for PTCA versus 23.7% for medical therapy, p = 0.50). The authors conculded that "PTCA of infarct-related arteries with TIMI 2 flow grade may modestly improve recovery of left ventricular function, and taht widespread application of PTCA in this setting should be deferred, pending demonstration that this benefit outweighs the risks of PTCA."

While informative, the Ellis study is limited by the fact that it was largely undertaken before the use of modern stent technology, aspiration, and antiplatelet therapies. Potential benefits of performing adjunctive PCI on an open artery following fibrinolytic administration in the modern era include:

  1. Further flow improvements to limit ongoing ischemia
  2. Redcuction in the risk of recurrent myocardial infarction, particulary if a stent is placed

The community standard among operators in Boston is to perform direct stenting without pre-dilation in an open artery following fibrinolytic therapy.

ACC / AHA Guidelines- Recommendations for PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion (DO NOT EDIT) [3]

Class IIb

1. PCI of a hemodynamically significant stenosis in a patent infarct artery greater than 24 hours after STEMI may be considered as part of an invasive strategy. (Level of Evidence: B)

Class III

1. PCI of a totally occluded infarct artery greater than 24 hours after STEMI is not recommended in asymptomatic patients with one or two-vessel disease if they are hemodynamically and electrically stable and do not have evidence of severe ischemia. (Level of Evidence: B)

Sources

  • The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction [4]
  • The 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction [3]

References

  1. Gibson CM, Karha J, Murphy SA; et al. (2003). "Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials". J. Am. Coll. Cardiol. 42 (1): 7–16. PMID 12849652. Unknown parameter |month= ignored (help)
  2. Ellis SG, Lincoff AM, George BS; et al. (1994). "Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group". Coron. Artery Dis. 5 (7): 611–5. PMID 7952423. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter |month= ignored (help)
  4. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK (2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)". Circulation. 110 (9): e82–292. PMID 15339869. Unknown parameter |month= ignored (help)

Template:SIB

Template:WH Template:WS